Medinotec (MDNC) Cash from Operations Growth (1y) (2023 - 2026)
Medinotec (MDNC) Cash from Operations Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | 122.43% |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | 76.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 76.80% |
| Feb 28, 2026 | -123.03% |
| Nov 30, 2025 | 242.65% |
| Aug 31, 2025 | 209.38% |
| May 31, 2025 | -392.99% |
| Feb 28, 2025 | 473.90% |
| Nov 30, 2024 | -57.03% |
| Aug 31, 2024 | 6,148.91% |
| May 31, 2024 | 194.33% |
| Feb 29, 2024 | -124.33% |
| Nov 30, 2023 | 254.18% |
| Aug 31, 2023 | 98.77% |
| May 31, 2023 | -302.77% |
| Feb 28, 2023 | 360.99% |